Cerevel Therapeutics Announces the Appointment of Dr. Ruth McKernan to its Board of Directors
CAMBRIDGE, Mass., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of...
News
Plus Therapeutics to Present at 13th Annual LD Micro Main Event Conference
AUSTIN, Texas, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage company focused on making...
Larimar Therapeutics Announces Completion of Dosing of the Single Ascending Dose Clinical Trial in Friedreich’s Ataxia Patients and Provides Program Update
- Preliminary data suggest that single subcutaneous injections of CTI-1601 were well tolerated at doses up to 100 mg -...
Adicet Bio to Participate in Fireside Chat at JMP Securities Hematology Summit
MENLO PARK, Calif., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing...
Theratechnologies Announces New Findings for its Lead Investigational Compound TH1902 for the Treatment of Several Additional Cancers
In addition to ovarian and triple-negative breast cancers, TH1902 shows pre-clinical in vivo efficacy in colorectal, pancreatic, melanoma and endometrial...
Orchard Therapeutics Reports OTL-201 Initial Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA)
Preliminary results from first patient treated with OTL-201 show over expression of the therapeutic enzyme and decrease in substrate levels...
Cerecor Announces FDA Acceptance of Investigational New Drug Application for CERC-007 for Treatment of Relapsed or Refractory Multiple Myeloma
ROCKVILLE, Md. and CHESTERBROOK, Pa., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on...
Checkmate Pharmaceuticals Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate CMP-001 in Combination with Nivolumab
CAMBRIDGE, Mass., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate Pharmaceuticals”), a clinical stage biopharmaceutical company...
CV Sciences, Inc. Announces Closing of Committed Equity Financing Transaction
SAN DIEGO, Dec. 08, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”),...
Aleafia Health Niagara Greenhouse Deemed EU GACP Compliant, Accelerating International Growth
TORONTO, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is...
Skylight Health Partners with GatherMed to Launch Remote Patient Monitoring Covered through Insurance for Patients with Hypertension
Over 45% or approximately 135 million Americans suffer from hypertension in the USSkylight patients will benefit significantly from access to...
Itamar Medical Announces Results from Multi-Center Study Validate Use of WatchPAT™ in Diagnosing Sleep Apnea in Patients with AFib
Results Further Support Use of WatchPAT for Home-Based Sleep Apnea Testing as an Effective Alternative to In-Lab PSG TestingCAESAREA, Israel,...
Philips again recognized for its commitment to action on climate change
Bouwdokken December 8, 2020 Philips achieves CDP ‘A List’ rating for the eighth consecutive year for its action on climate...
CENTOGENE and Alnylam Pharmaceuticals Launch a New Clinical Program Aimed at Revolutionizing the Diagnosis of Hereditary Transthyretin-Related Amyloidosis (“ATTRv”)
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN and MUNICH, Germany, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG),...
Ocuphire to be Featured in Cantor Fitzgerald Fireside Chat with Equity Research Analyst Kristen Kluska
FARMINGTON HILLS, Mich., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing...
Axsome Therapeutics Announces Positive Results from the COMET-SI Trial of AXS-05 in Patients with Major Depressive Disorder Who Have Suicidal Ideation
68% reduction in MADRS Suicidality Item score by Week 1, and 82% reduction by Week 4 Resolution of suicidal ideation...
CampDoc and myCAMPapp Announce New Partnership for Mobile Application Integration
ANN ARBOR, Mich., Dec. 08, 2020 (GLOBE NEWSWIRE) -- CampDoc, the leading electronic health record system for camps, has partnered...
Amryt Announces $40m Private Placement with Leading Biotech Investors
Amryt Announces $40m Private Placement with Leading Biotech Investors DUBLIN, Ireland, and Boston MA, December 8, 2020, Amryt (Nasdaq: AMYT,...
Phytosciences Ghana Publishes Report on How Cannabis Affects Anxiety, Depression, ADHD, and Schizophrenia
ACCRA, Ghana, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Phytosciences Ghana Limited, a subsidiary of Phytosciences GmBH, published a report titled...
MEDITECH’s High Availability SnapShot Provides Cloud-Based Backup Protection
Avera leverages EHR solution for added reliability in the event of unexpected downtime WESTWOOD, Mass.--(BUSINESS WIRE)--MEDITECH customers can now enhance...